McKesson
MCK
#187
Rank
NZ$196.16 B
Marketcap
NZ$1,589
Share price
0.19%
Change (1 day)
51.39%
Change (1 year)
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.

EPS for McKesson (MCK)

EPS in 2025 (TTM): NZ$60.12

According to McKesson's latest financial reports the company's current EPS (TTM) is NZ$58.47. an increase over its 2024 EPS that were of NZ$36.77.

EPS history for McKesson from 2014 to 2025

Annual EPS

Year EPS Change
2025NZ$58.2258.33%
2024NZ$36.77-1.17%
2023NZ$37.201%
2022NZ$36.83144.72%
2021NZ$15.05-133.49%
2020NZ-$44.94451.13%
2019NZ-$8.15266.17%
2018NZ-$2.23-105.85%
2017NZ$38.07166.28%
2016NZ$14.300.71%
2015NZ$14.2014.44%
2014NZ$12.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Cerner
CERN
NZ$3.35-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Henry Schein
HSIC
NZ$5.34-90.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AmerisourceBergen
ABC
NZ$13.88-76.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
NZ$11.15-80.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
NZ-$0.45-100.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Patterson Companies
PDCO
NZ$2.61-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Computer Programs and Systems
CPSI
NZ-$5.27-109.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Veradigm
MDRX
NZ$0.84-98.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Owens & Minor
OMI
NZ-$29.14-149.84%๐Ÿ‡บ๐Ÿ‡ธ USA